Lexicon Pharmaceuticals and Bristol-Myers Squibb, though both in pharma, are leagues apart in scale, profitability, and risk.

Bristol-Myers Squibb finds itself in the billionaire investors’ bargain bin, but with some surprisingly luxe packaging. The ...

We recently published a list of the 15 Best and Cheap Stocks to Buy According to Billionaires. In this article, we are going ...

Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic ...

Jiangsu Hengrui Pharmaceuticals and its partner Elevar Therapeutics will have to wait even longer before their PD-1 inhibitor ...

Pharmaceutical company Novartis is laying off more than 400 US employees who report to its East Hanover facility as part of a ...

We recently published a list of 12 Incredibly Cheap Dividend Stocks to Buy Now. In this article, we are going to take a look ...

Vermont Business Magazine Howard Center announces its spring conference, Perspectives 2025: Confronting Stigma, Cultivating Compassion, on May 13, 2025, from 8:30 a.m. to 4:30 p.m. This year's event ...

Bullish option flow detected in Bristol Myers ( BMY) Squibb with 11,821 calls trading, 2x expected, and implied vol increasing almost 2 points to 27.82%. May-25 67.5 calls and Mar-25 60 calls are the ...

Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...

Automated three-dimensional total-body photography improves the efficiency of positive malignant biopsies and reduces ...

In this video, Michael Cecchini, MD, discusses “practice-changing” data from the CheckMate 8HW study, which were presented at ASCO Gastrointestinal Cancers Symposium.